TNF and arthritic joint disease: This pathway seems not to contribute to the pathology of arthritis during the stages of flare-up and acute inflammation, but may well propagate chronic catabolic processes in a joint, even when IL-1β or TNF-α are not expressed at pathological levels or are captured pharmacologically.